Literature DB >> 32525008

Overexpression of angiotensin converting enzyme 2 reduces anxiety-like behavior in female mice.

Annette D de Kloet1, Karlena M Cahill2, Karen A Scott3, Eric G Krause4.   

Abstract

Accumulating evidence has revealed an intricate role for the renin-angiotensin system (RAS) in the progression or alleviation of stress-related disorders. Along these lines, the 'pro-stress' actions of angiotensin-II (Ang-II) are largely thought to be mediated by the angiotensin type-1a receptor (AT1aR). On the other hand, a counter regulatory limb of the RAS that depends on the conversion of Ang-II to angiotensin-(1-7) by angiotensin-converting enzyme 2 (ACE2) has been postulated to exert stress-dampening actions. We have previously found that augmenting ACE2 activity is potently anxiolytic and blunts stress-induced activation of the hypothalamic-pituitary-adrenal (HPA) axis in male mice. Whether increasing ACE2 activity also relieves stress and anxiety in females has not yet been determined. Consequently, this series of experiments tests the hypothesis that augmenting ACE2 expression is anxiolytic and dampens the activity of the HPA axis in female mice. Using the Cre-LoxP system, we generated female mice that were homo-, heterozygous or wild-type for a mutated allele resulting in ubiquitous overexpression of ACE2. Next, we used qPCR to determine that levels of ACE2 mRNA isolated from central and peripheral tissues was dependent on genotype. That is, mice homo- and heterozygous for the ACE2 overexpression had significantly greater levels of ACE2 mRNA relative to littermate matched wild-type controls. Interestingly, anxiety-like behavior as determined by the elevated plus maze, light-dark box and novelty-induced hypophagia tests was also affected by genotype. Specifically, ACE2 overexpression significantly decreased anxiety-like behavior in paradigms dependent on approach-avoidance conflict and novelty; however, locomotor activity was similar amongst the genotypes. Final experiments measured plasma corticosterone to evaluate whether increasing ACE2 alters basal and/or stress-induced HPA axis activity. In contrast to what was previously found in males, increasing ACE2 expression had no effect on plasma corticosterone under basal conditions or subsequent to an acute restraint challenge. Collectively, these results suggest that increasing ACE2 expression potently elicits anxiolysis in female mice without altering HPA axis activity.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32525008      PMCID: PMC7503770          DOI: 10.1016/j.physbeh.2020.113002

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  32 in total

1.  Males still dominate animal studies.

Authors:  Irving Zucker; Annaliese K Beery
Journal:  Nature       Date:  2010-06-10       Impact factor: 49.962

Review 2.  Blockade of brain angiotensin II AT1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: Therapeutic implications.

Authors:  Juan M Saavedra; Enrique Sánchez-Lemus; Julius Benicky
Journal:  Psychoneuroendocrinology       Date:  2010-10-29       Impact factor: 4.905

3.  Blood-borne angiotensin II acts in the brain to influence behavioral and endocrine responses to psychogenic stress.

Authors:  Eric G Krause; Annette D de Kloet; Karen A Scott; Jonathan N Flak; Kenneth Jones; Michael D Smeltzer; Yvonne M Ulrich-Lai; Stephen C Woods; Steven P Wilson; Lawrence P Reagan; James P Herman; Randall R Sakai
Journal:  J Neurosci       Date:  2011-10-19       Impact factor: 6.167

4.  Reduced anxiety-like behavior in transgenic rats with chronically overproduction of angiotensin-(1-7): Role of the Mas receptor.

Authors:  Lucas M Kangussu; Ana Flávia Almeida-Santos; Fabrício A Moreira; Marco A P Fontes; Robson A S Santos; Daniele C Aguiar; Maria José Campagnole-Santos
Journal:  Behav Brain Res       Date:  2017-05-11       Impact factor: 3.332

5.  Angiotensin-(1-7) attenuates the anxiety and depression-like behaviors in transgenic rats with low brain angiotensinogen.

Authors:  Lucas M Kangussu; Ana F Almeida-Santos; Michael Bader; Natalia Alenina; Marco Antônio P Fontes; Robson A S Santos; Daniele C Aguiar; Maria José Campagnole-Santos
Journal:  Behav Brain Res       Date:  2013-09-07       Impact factor: 3.332

6.  Repeated stress increases the density of angiotensin II binding sites in rat paraventricular nucleus and subfornical organ.

Authors:  E Castren; J M Saavedra
Journal:  Endocrinology       Date:  1988-01       Impact factor: 4.736

7.  Coupling corticotropin-releasing-hormone and angiotensin converting enzyme 2 dampens stress responsiveness in male mice.

Authors:  Lei A Wang; Annette D de Kloet; Michael D Smeltzer; Karlena M Cahill; Helmut Hiller; Erin B Bruce; David J Pioquinto; Jacob A Ludin; Michael J Katovich; Mohan K Raizada; Eric G Krause
Journal:  Neuropharmacology       Date:  2018-05-01       Impact factor: 5.250

8.  Anxiolytic- and antidepressant-like effects of angiotensin-(1-7) in hypertensive transgenic (mRen2)27 rats.

Authors:  Ana Flávia Almeida-Santos; Lucas M Kangussu; Fabrício A Moreira; Robson A S Santos; Daniele C Aguiar; Maria José Campagnole-Santos
Journal:  Clin Sci (Lond)       Date:  2016-04-20       Impact factor: 6.124

Review 9.  Anxiety disorders.

Authors:  Michelle G Craske; Murray B Stein; Thalia C Eley; Mohammed R Milad; Andrew Holmes; Ronald M Rapee; Hans-Ulrich Wittchen
Journal:  Nat Rev Dis Primers       Date:  2017-05-04       Impact factor: 52.329

10.  Characterization of the cardiac renin angiotensin system in oophorectomized and estrogen-replete mRen2.Lewis rats.

Authors:  Hao Wang; Jewell A Jessup; Zhuo Zhao; Jaqueline Da Silva; Marina Lin; Lindsay M MacNamara; Sarfaraz Ahmad; Mark C Chappell; Carlos M Ferrario; Leanne Groban
Journal:  PLoS One       Date:  2013-10-25       Impact factor: 3.240

View more
  3 in total

Review 1.  Brain angiotensin converting enzyme-2 in central cardiovascular regulation.

Authors:  Mazher Mohammed; Clara Berdasco; Eric Lazartigues
Journal:  Clin Sci (Lond)       Date:  2020-10-16       Impact factor: 6.124

2.  Central Administration of Angiotensin-(1-7) Improves Vasopressin Impairment and Hypotensive Response in Experimental Endotoxemia.

Authors:  Patrícia Passaglia; Felipe de Lima Faim; Marcelo Eduardo Batalhão; Angelita Maria Stabile; Lusiane Maria Bendhack; José Antunes-Rodrigues; Riccardo Lacchini; Evelin Capellari Carnio
Journal:  Cells       Date:  2021-01-08       Impact factor: 6.600

Review 3.  ACE2, Circumventricular Organs and the Hypothalamus, and COVID-19.

Authors:  Wei-Yi Ong; R L Satish; Deron R Herr
Journal:  Neuromolecular Med       Date:  2022-04-22       Impact factor: 4.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.